Prolapse

  1. (CARE) Brubaker L, Cundiff GW, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354(15):1557-1566. http://doi.org/10.1056/NEJMoa054208

  2. Cundiff GW, Amundsen CL, Bent AE, et al. The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. Am J Obstet Gynecol. 2007;196(4):405.e401-408. http://doi.org/10.1016/j.ajog.2007.02.018

  3. Gustilo-Ashby AM, Paraiso MF, Jelovsek JE, Walters MD, Barber MD. Bowel symptoms 1 year after surgery for prolapse: further analysis of a randomized trial of rectocele repair. Am J Obstet Gynecol. 2007;197(1):76.e71-75. http://doi.org/10.1016/j.ajog.2007.02.045

  4. Barber MD, Brubaker L, Nygaard I, et al. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol. 2009;114(3):600-609. http://doi.org/10.1097/AOG.0b013e3181b2b1ae

  5. Paraiso MFR, Jelovsek JE, Frick A, Chen CCG, Barber MD. Laparoscopic compared with robotic sacrocolpopexy for vaginal prolapse: a randomized controlled trial. Obstet Gynecol. 2011;118(5):1005-1013. http://doi.org/10.1097/AOG.0b013e318231537c

  6. Barber MD, Brubaker L, Burgio KL, et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. Jama. 2014;311(10):1023-1034. http://doi.org/10.1001/jama.2014.1719

  7. Milani AL, Damoiseaux A, IntHout J, Kluivers KB, Withagen MIJ. Long-term outcome of vaginal mesh or native tissue in recurrent prolapse: a randomized controlled trial. International Urogynecology Journal. 2018;29(6):847-858. http://doi.org/10.1007/s00192-017-3512-3

  8. Jelovsek JE, Barber MD, Brubaker L, et al. Effect of Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation With or Without Perioperative Behavioral Therapy for Pelvic Organ Vaginal Prolapse on Surgical Outcomes and Prolapse Symptoms at 5 Years in the OPTIMAL Randomized Clinical Trial. Jama. 2018;319(15):1554-1565. http://doi.org/10.1001/jama.2018.2827

  9. Kowalski JT, Genadry R, Ten Eyck P, Bradley CS. A randomized controlled trial of permanent vs absorbable suture for uterosacral ligament suspension. Int Urogynecol J. 2021;32(4):785-790. http://doi.org/10.1007/s00192-020-04244-1

Urinary & Fecal Continence

  1. (SISTer) Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med. 2007;356(21):2143-2155. http://doi.org/10.1056/NEJMoa070416

  2. Markland AD, Kraus SR, Richter HE, et al. Prevalence and risk factors of fecal incontinence in women undergoing stress incontinence surgery. Am J Obstet Gynecol. 2007;197(6):662.e661-667. http://doi.org/10.1016/j.ajog.2007.08.062

  3. (SUmiT) Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438-1443. http://doi.org/10.1016/j.juro.2009.12.036

  4. (TOMUS) Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362(22):2066-2076. http://doi.org/10.1056/NEJMoa0912658

  5. Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2010;115(3):609-617. http://doi.org/10.1097/AOG.0b013e3181d055d4

  6. Dmochowski R, Chapple C, Nitti VW, et al. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol. 2010;184(6):2416-2422. http://doi.org/10.1016/j.juro.2010.08.021

  7. (ABC) Visco AG, Brubaker L, Richter HE, et al. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med. 2012;367(19):1803-1813. http://doi.org/10.1056/NEJMoa1208872

  8. Wei JT, Nygaard I, Richter HE, et al. A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med. 2012;366(25):2358-2367. http://doi.org/10.1056/NEJMoa1111967

  9. (VAlUE) Nager CW, Brubaker L, Litman HJ, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med. 2012;366(21):1987-1997. http://doi.org/10.1056/NEJMoa1113595

  10. Labrie J, Berghmans BLCM, Fischer K, et al. Surgery versus Physiotherapy for Stress Urinary Incontinence. New England Journal of Medicine. 2013;369(12):1124-1133. http://doi.org/10.1056/NEJMoa1210627

  11. (ROSETTA) Amundsen CL, Richter HE, Menefee SA, et al. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial. Jama. 2016;316(13):1366-1374. http://doi.org/10.1001/jama.2016.14617

  12. Jelovsek JE, Markland AD, Whitehead WE, et al. Controlling faecal incontinence in women by performing anal exercises with biofeedback or loperamide: a randomised clinical trial. The lancet Gastroenterology & hepatology. 2019;4(9):698-710. http://doi.org/10.1016/s2468-1253(19)30193-1

Mesh issues

  1. Altman D, Väyrynen T, Engh ME, Axelsen S, Falconer C. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med. 2011;364(19):1826-1836. http://doi.org/10.1056/NEJMoa1009521

  2. Nguyen JN, Jakus-Waldman SM, Walter AJ, White T, Menefee SA. Perioperative complications and reoperations after incontinence and prolapse surgeries using prosthetic implants. Obstet Gynecol. 2012;119(3):539-546. http://doi.org/10.1097/AOG.0b013e3182479283

Other

  1. Jeppson PC, Jakus-Waldman S, Yazdany T, et al. Microscopic Hematuria as a Screening Tool for Urologic Malignancies in Women. Female Pelvic Med Reconstr Surg. 2021;27(1):9-15. http://doi.org/10.1097/spv.0000000000000726